The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19
Open Access
- 23 December 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 586073
- https://doi.org/10.3389/fimmu.2020.586073
Abstract
Since the December 2019 outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, the infection has spread locally and globally resulting in a pandemic. As the numbers of confirmed diagnoses and deaths continue to rise, COVID-19 has become the focus of international public health. COVID-19 is highly contagious, and there is no effective treatment yet. New treatment strategies are urgently needed to improve the treatment success rate of severe and critically ill patients. Increasing evidence has shown that a cytokine storm plays an important role in the progression of COVID-19. The artificial-liver blood-purification system (ALS) is expected to improve the outcome of the cytokine storm. In the present study, the levels of cytokines were detected in 12 COVID-19 patients pre- and post-ALS with promising results. The present study shows promising evidence that ALS can block the cytokine storm, rapidly remove the inflammatory mediators, and hopefully, suppress the progression of the disease, thereby providing a new strategy for the clinical treatment of COVID-19.This publication has 48 references indexed in Scilit:
- The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal OutcomesScientific Reports, 2015
- Asef mediates HGF protective effects against LPS-induced lung injury and endothelial barrier dysfunctionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2015
- Continuous Hemodiafiltration with a Cytokine-Adsorbing Hemofilter in Patients with Septic Shock: A Preliminary ReportBlood Purification, 2014
- Evaluation of Plasma Exchange and Continuous Veno‐Venous Hemofiltration for the Treatment of Severe Avian Influenza A (H7N9): A Cohort StudyTherapeutic Apheresis and Dialysis, 2014
- Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injuryCell Research, 2013
- Continuous Hemodiafiltration with a Cytokine-Adsorbing Hemofilter for SepsisBlood Purification, 2012
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaNature Medicine, 2006
- Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeClinical and Experimental Immunology, 2004
- Review of Methods to Remove Protein-Bound Substances in Liver FailureThe International Journal of Artificial Organs, 2002